New therapies expected to help reduce future visual burden of age-related eye disease
Monday, April 13, 2009 - 15:49
in Health & Medicine
The prevalence of the eye disease age-related macular degeneration is projected to increase substantially by 2050, but the use of new therapies is expected to help mitigate its effects on vision, according to results of simulation modeling reported in the April issue of Archives of Ophthalmology, one of the JAMA/Archives journals.